HealthcareServices

Genetic Toxicology Testing Market Size and Demand Forecast 2026–2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genetic toxicology testing market from 2026–2035 with trusted insights from The Business Research Company

How is the Genetic Toxicology Testing Market size predicted to change over the forecast window of 2026–2035?

The genetic toxicology testing market has experienced significant expansion recently. Projections indicate it will increase from $1.8 billion in 2025 to $1.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. Factors such as regulatory safety requirements, an increase in pharmaceutical R&D, the early integration of in vivo testing, monitoring of industrial chemicals, and environmental health studies are considered contributors to its historical growth.

The genetic toxicology testing market size is anticipated to experience substantial growth over the coming years. It is projected to reach $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This expansion during the forecast period is primarily driven by the move towards alternative testing methods, more stringent regulatory frameworks, advancements in biologics development, the need for safer chemicals, and the increasing scope of toxicogenomics. Noteworthy trends for the same period encompass a heightened application of genotoxicity testing in drug development, the increasing adoption of in vitro genetic toxicology assays, an intensifying regulatory focus on chemical safety testing, the broadening of environmental genotoxicity assessment, and a greater demand from pharmaceutical safety studies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

Which Drivers Are Contributing To The Expansion Of The Genetic Toxicology Testing Market?

The rising need for individualized healthcare is anticipated to drive the expansion of the genetic toxicology testing market in the future. This medical approach, known as personalized medicine, customizes healthcare choices, procedures, treatments, and goods for each patient, considering their anticipated reaction or likelihood of disease. The personalized medicine market has seen significant positive momentum, attributed to advancements in genetics, a deeper comprehension of diseases, the presence of diagnostic tools reliant on biomarkers, healthcare programs focused on value, and its incorporation into both clinical settings and research. Through offering crucial data on genetic differences, vulnerability to agents causing genetic damage, and how patients respond to treatments, genetic toxicology testing plays a vital role in personalized medicine. Illustratively, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 novel personalized medicines for individuals with rare disease patients, an increase from six approvals in 2022. Consequently, the growing requirement for personalized medicine fuels the genetic toxicology testing market.

What Segment Classifications Make Up The Genetic Toxicology Testing Market?

The genetic toxicology testing market covered in this report is segmented –

1) By Testing Method: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent)

Which Competitive Trends Are Impacting The Structure Of The Genetic Toxicology Testing Market?

Leading companies within the genetic toxicology testing market are concentrating on creating innovative drug screening platforms, including high throughput transcriptomics, to enhance the precision and efficiency of identifying potential genetic toxins. High throughput transcriptomics signifies a technology-driven approach that enables the extensive measurement of gene expression (the transcriptome) across many samples in parallel, typically utilizing methods like RNA sequencing (RNA-seq). This allows researchers to assess, in a high-throughput manner, how various compounds (e.g., drugs or chemicals) perturb global cellular gene expression, which assists in predicting toxicological effects, modes of action (MOA), and potential genotoxicity. For instance, in September 2024, Toxys, a Netherlands-based biotech company specializing in in vitro toxicology solutions, launched MutaTracker. This mammalian cell-based mutagenicity and genotoxicity assay integrates its established ToxTracker reporter system with error-corrected single molecule mutation sequencing (SMM seq). This platform facilitates ultra-sensitive detection of point mutations, even those as rare as 1 in 107 bases, and provides detailed insight into the genotoxic mode of action, thereby improving accuracy and reducing false positives compared to traditional cytogenetic assays.

Which Leading Companies Dominate The Genetic Toxicology Testing Market Share?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genetic Toxicology Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Browse Through More Reports Similar to the Global Genetic Toxicology Testing Market 2026, By The Business Research Company

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795